Ovarian Sex Cord-Stromal Tumor · Surgery
Granulosa cell tumor etc. early young fertility-sparing (ipsilateral adnexa + staging); completed childbearing TAH-BSO + staging; estrogenic type needs endometrial assessment.
Early young → fertility-sparing surgery: Granulosa cell/Sertoli-Leydig cell tumor etc., early and young → fertility-sparing surgery (ipsilateral adnexa + staging); adult granulosa …
Step-by-step decision
Choose step by step as prompted; reaching an endpoint gives the management recommendation. You can go back a step or restart anytime.
Full pathway
- [Decision] Type + fertility + endocrineType? Fertility-sparing? Endocrine symptoms?
- Granulosa cell tumor etc., early, young, wants fertility preservation → Early young → fertility-sparing surgery
- Completed childbearing/advanced → Completed childbearing/advanced → staging/debulking
- Endocrine symptoms (estrogen/androgen) needing assessment → Endocrine type → assess the endometrium
- [End] Early young → fertility-sparing surgeryGranulosa cell/Sertoli-Leydig cell tumor etc., early and young → fertility-sparing surgery (ipsilateral adnexa + staging); adult granulosa cell tumors can recur late, long-term follow-up (inhibin B/AMH).
- [End] Completed childbearing/advanced → staging/debulkingCompleted childbearing/advanced → total hysterectomy + bilateral salpingo-oophorectomy + staging/debulking; chemotherapy for advanced/recurrent disease.
- [End] Endocrine type → assess the endometriumEstrogenic presentation (granulosa cell tumor) → assess the endometrium pre/intraoperatively (exclude concurrent endometrial hyperplasia/cancer); androgenic features usually regress postoperatively.
Source guidelines & references
- Ovarian sex cord-stromal tumors (NCCN/ESGO; granulosa cell tumor inhibin follow-up)
This pathway is our own synthesis of the decision logic in the guidelines above (not the guideline verbatim); thresholds and workflows change as guidelines update — in practice follow the latest guideline, your institution's protocol and the individual patient.